Quantitation of covalently closed circular hepatitis B virus DNA in chronic B patients

Hepatology

Volumn 40, Issue 3, 2004, Pages 727-737

  Wong, Danny Ka Ho ^a   Yuen, Man Fung ^a   Yuan, HeJun ^a,b   Sum, Simon Siu Man ^a   Hui, Ghee Kin ^a   Hall, Jeff ^c   Lai, Ching Lung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b FUDAN UNIVERSITY   (China)

^c Third Wave Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULAR DNA; COVALENTLY CLOSED CIRCULAR DNA; HEPATITIS E ANTIGEN; UNCLASSIFIED DRUG; VIRUS DNA; HEPATITIS B(E) ANTIGEN;

ACCURACY; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE COURSE; DNA EXTRACTION; GENE AMPLIFICATION; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; BLOOD; GENETICS; HEPATITIS B VIRUS; MOLECULAR GENETICS; VIROLOGY;

BASE SEQUENCE; DNA, CIRCULAR; DNA, VIRAL; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 4644296081     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20353     Document Type: Article

References (49)

1. Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337:1733-1745.
2. Moraleda G, Saputelli J, Aldrich CE, Averett D, Condreay L, Mason WS. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J Virol 1997;71:9392-9399.
3. Delaney WE 4th, Miller TG, Isom HC. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2′,3′-dideoxy-3′-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA. Antimicrob Agents Chemother 1999;43:2017-2026.
4. Lai CL, Ching CK, Tung AK, Li E, Young J, Hill A, et al. Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. HEPATOLOGY 1997;25:241-244.
5. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000;64:51-68.
6. Gong SS, Jensen AD, Wang H, Rogler CE. Duck hepatitis B virus integrations in LMH chicken hepatoma cells: identification and characterization of new episomally derived integrations. J Virol 1995;69:8102-8108.
7. Gong SS, Jensen AD, Chang CJ, Rogler CE. Double-stranded linear duck hepatitis B virus (DHBV) stably integrates at a higher frequency than wild-type DHBV in LMH chicken hepatoma cells. J Virol 1999;73:1492-1502.
8. Yang W, Summers J. Integration of hepadnavirus DNA in infected liver: evidence for a linear precursor. J Virol 1999;73:9710-9717.
9. Yang W, Summers J. Illegitimate replication of linear hepadnavirus DNA through nonhomologous recombination. J Virol 1995;69:4029-4036.
10. Yang W, Mason WS, Summers J. Covalently closed circular viral DNA formed from two types of linear DNA in woodchuck hepatitis virus-infected liver. J Virol 1996;70:4567-4575.
11. Kock J, Schlicht HJ. Analysis of the earliest steps of hepadnavirus replication: genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity. J Virol 1993;67:4867-4874.
12. Addison WR, Wong WW, Fischer KP, Tyrrell DL. A quantitative competitive PCR assay for the covalently closed circular form of the duck hepatitis B virus. Antiviral Res 2000;48:27-37.
13. Zhou T, Guo JT, Nunes FA, Molnar-Kimber KL, Wilson JM, Aldrich CE, et al. Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections. J Virol 2000;74:11754-11763.
14. Lu M, Hilken G, Yang D, Kemper T, Roggendorf M. Replication of naturally occurring woodchuck hepatitis virus deletion mutants in primary hepatocyte cultures and after transmission to naive woodchucks. J Virol 2001;75:3811-3818.
15. Zhu Y, Yamamoto T, Cullen J, Saputelli J, Aldrich CE, Miller DS, et al. Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol 2001;75:311-322.
16. Addison WR, Walters KA, Wong WW, Wilson JS, Madej D, Jewell LD, et al. Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication. J Virol 2002;76:6356-6363.
17. Jun-Bin S, Zhi C, Wei-Qin N, Jun F. A quantitative method to detect HBV cccDNA by chimeric primer and real-time polymerase chain reaction. J Virol Methods 2003;112:45-52.
18. Laras A, Dimou E, Kostamena A, Koskinas J, Hadziyannis SJ. Quantitative analysis of hepatitis B virus replicative intermediates in the liver: a comparison of pregenomic RNA vs cccDNA detection [Abstract]. HEPATOLOGY 2003;38(Suppl):668A.
19. Kock J, Theilmann L, Galle P, Schlicht HJ. Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus. HEPATOLOGY 1996;23:405-413.
20. Stoll-Becker S, Repp R, Glebe D, Schaefer S, Kreuder J, Kann M, et al. Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients. J Virol 1997;71:5399-5407.
21. Kwiatkowski RW, Lyamichev V, de Arruda M, Neri B. Clinical, genetic, and pharmacogenetic applications of the Invader assay. Mol Diagn 1999;4:353-364.
22. Arad U. Modified Hirt procedure for rapid purification of extrachromosomal DNA from mammalian cells. Biotechniques 1998;24:760-762.
23. Lee CZ, Huang GT, Yang PM, Sheu JC, Lai MY, Chen DS. Correlation of HBV DNA levels in serum and liver of chronic hepatitis B patients with cirrhosis. Liver 2002;22:130-135.
24. Hall JG, Eis PS, Law SM, Reynaldo LP, Prudent JR, Marshall DJ, et al. Sensitive detection of DNA polymorphisms by the serial invasive signal amplification reaction. Proc Natl Acad Sci U S A 2000;97:8272-8277.
25. Klein C, Bock CT, Wedemeyer H, Wustefeld T, Locarnini S, Dienes HP, et al. Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA. Gastroenterology 2003;125:9-18.
26. Bock CT, Tillmann HL, Torresi J, Klempnauer J, Locarnini S, Manns MP, et al. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation. Gastroenterology 2002;122:264-273.
27. Mason AL, Xu L, Guo L, Kuhns M, Perrillo RP. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. HEPATOLOGY 1998;27:1736-1742.
28. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. HEPATOLOGY 1981;1:431-435.
29. Pawlotsky JM. Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics. J Hepatol 2003;39(Suppl 1):S31-S35.
30. Pawlotsky JM. Molecular diagnosis of viral hepatitis. Gastroenterology 2002;122:1554-1568.
31. Lyamichev VI, Brow MA, Dahlberg JE. Structure-specific endonucleolytic cleavage of nucleic acids by eubacterial DNA polymerases. Science 1993;260:778-783.
32. Lyamichev VI, Mast AL, Hall JG, Prudent JR, Kaiser MW, Takova T, et al. Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nat Biotech 1999;17:292-296.
33. Lyamichev VI, Kaiser MW, Lyamicheva NE, Vologodskii AV, Hall JG, Ma WP, et al. Experimental and theoretical analysis of the invasive signal amplification reaction. Biochemistry 2000;39:9523-9532.
34. Yang W, Summers J. Infection of ducklings with virus particles containing linear double-stranded duck hepatitis B virus DNA: illegitimate replication and reversion. J Virol 1998;72:8710-8717.
35. Robinson WS. The role of hepatitis B virus in the development of primary hepatocellular carcinoma: Part I. J Gastroenterol Hepatol 1992;7:622-638.
36. Liu MC, Yu M, Zhang NL, Gong WB, Wang Y, Piao WH, et al. Dynamic analysis of hepatitis B virus DNA and its antigens in 2.2.15 cells. J Viral Hepat 2004;11:124-129.
37. Wu CH, Ouyang EC, Walton CM, Wu GY. Human hepatocytes transplanted into genetically immunocompetent rats are susceptible to infection by hepatitis B virus in situ. J Viral Hepat 2001;8:111-119.
38. Su Q, Wang SF, Chang TE, Breitkreutz R, Hennig H, Takegoshi K, et al. Circulating hepatitis B virus nucleic acids in chronic infection: representation of differently polyadenylated viral transcripts during progression to nonreplicative stages. Clin Cancer Res 2001;7:2005-2015.
39. Zhang W, Hacker HJ, Tokus M, Bock T, Schröder CH. Patterns of circulating hepatitis B virus serum nucleic acids during lamivudine therapy. J Med Virol 2003;71:24-30.
40. Breitkreutz R, Zhang W, Lee M, Hoffmann A, Tokus M, Su Q, et al. Hepatitis B virus nucleic acids circulating in the blood: distinct patterns in HBs carriers with hepatocellular carcinoma. Ann N Y Acad Sci 2001;945:195-206.
41. Zhang YY, Zhang BH, Theele D, Litwin S, Toll E, Summers J. Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver. Proc Natl Acad Sci U S A 2003;100:12372-12377.
42. Torii N, Hasegawa K, Joh R, Hayashi N. Configuration and replication competence of hepatitis B virus DNA in peripheral blood mononuclear cells from chronic hepatitis B patients and patients who have recovered from acute self-limited hepatitis. Hepatol Res 2003;25:234-243.
43. Cabrerizo M, Bartolom J, Caramelo C, Barril G, Carreno V. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. HEPATOLOGY 2000;32:116-123.
44. Davis GL, Hoofnagle JH, Waggoner JG. Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology 1984;86:230-235.
45. Yuen MF, Yuan HJ, Hui CK, Wong DKH, Wong WM, Chan AOO, et al. A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy. Gut 2003;52:416-4l9.
46. Yuen MF, Wong DKH, Sablon E, Tse E, Ng IOL, Yuan HJ, et al. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histologic and clinical aspects. HEPATOLOGY 2004;39:1694-1701.
47. Dienstag JL, Schiff ER, Mitchell M, Casey DE Jr, Gitlin N, Lissoos T, et al. Extended lamivudine retreatment for chronic hepatitis B: maintenance of viral suppression after discontinuation of therapy. HEPATOLOGY 1999:30:1082-1087.
48. Lok AS, McMahon BJ. Practice Guidelines Committee, American Association for the Study of Liver Diseases. HEPATOLOGY 2001;34:1225-1241.
49. Yuen MF, Sablon E, Yuan HJ, Hui CK, Wong DKH, Doutreloigne J, et al. Relationship between the development of precore and core promoter mutations and hepatitis B e antigen seroconversion in patients with chronic hepatitis B virus. J Infect Dis 2002;186:1335-1338.